{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:44Z","timestamp":1761518804501},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00104-005-1110-2","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T03:32:37Z","timestamp":1132111957000},"page":"15-24","source":"Crossref","is-referenced-by-count":15,"title":["Das famili\u00e4re Nebenschilddr\u00fcsenkarzinom"],"prefix":"10.1007","volume":"77","author":[{"given":"O.","family":"Gimm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nguyen\u00a0Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schneyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bloching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. M.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. T.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1110_CR1","first-page":"N18","volume":"2","author":"Adami","year":"2002","unstructured":"Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17 Suppl 2: N18\u201323","journal-title":"J Bone Miner Res 17 Suppl"},{"key":"1110_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000076584","volume":"1","author":"Brandi","year":"2004","unstructured":"Brandi ML, Falchetti A (2004) Genetics of primary hyperparathyroidism. Urol Int 72 Suppl 1:11\u201316","journal-title":"Urol Int 72 Suppl"},{"key":"1110_CR3","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR4","first-page":"2042","volume":"85","author":"Carling","year":"2000","unstructured":"Carling T, Szabo E, Bai M et al. (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85:2042\u20132047","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","volume":"257","author":"Carling","year":"2005","unstructured":"Carling T, Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27\u201337.#","journal-title":"J Intern Med"},{"key":"1110_CR6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676\u2013680","journal-title":"Nat Genet"},{"key":"1110_CR7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1210\/jc.2003-031016","volume":"89","author":"Cavaco","year":"2004","unstructured":"Cavaco BM, Guerra L, Bradley KJ et al. (2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747\u20131752","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR8","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S et al. (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583\u20135591","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR9","first-page":"457","volume":"Endocrinol","author":"Cetani","year":"2002","unstructured":"Cetani F, Pardi E, Giovannetti A et al. (2002) Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 56:457\u2013464","journal-title":"Clin"},{"key":"1110_CR10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404\u2013407","journal-title":"Science"},{"key":"1110_CR11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2796.2003.01168.x","volume":"253","author":"Chen","year":"2003","unstructured":"Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT (2003) Hyperparathyroidism-jaw tumour syndrome. J Intern Med 253:634\u2013642","journal-title":"J Intern Med"},{"key":"1110_CR12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1507\/endocrj.50.527","volume":"50","author":"Chen","year":"2003","unstructured":"Chen Q, Kaji H, Nomura R, Sowa H et al. (2003) Trial to predict malignancy of affected parathyroid glands in primary hyperparathyroidism. Endocr J 50:527\u2013534","journal-title":"Endocr J"},{"key":"1110_CR13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/jcp.30.10.966","volume":"30","author":"Dinnen","year":"1977","unstructured":"Dinnen JS, Greenwoood RH, Jones JH, Walker DA, Williams ED (1977) Parathyroid carcinoma in familial hyperparathyroidism. J Clin Pathol 30:966\u2013975","journal-title":"J Clin Pathol"},{"key":"1110_CR14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4065\/77.8.866","volume":"77","author":"Dionisi","year":"2002","unstructured":"Dionisi S, Minisola S, Pepe J, De Geronimo S, Paglia F, Memeo L, Fitzpatrick LA (2002) Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc 77:866\u2013869","journal-title":"Mayo Clin Proc"},{"key":"1110_CR15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D et al. (1993) Mutations in the RET proto-oncogene are associated with MEN\u00a02A and FMTC. Hum Mol Genet 2:851\u2013856","journal-title":"Hum Mol Genet"},{"key":"1110_CR16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.surg.2004.07.018","volume":"136","author":"Dralle","year":"2004","unstructured":"Dralle H, Sekulla C, Haerting J et al. (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310\u20131322","journal-title":"Surgery"},{"key":"1110_CR17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575\u20131579","journal-title":"JAMA"},{"key":"1110_CR18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.0.1380557","volume":"138","author":"Fujikawa","year":"1998","unstructured":"Fujikawa M, Okamura K, Sato K, Mizokami T, Tamaki K, Yanagida T, Fujishima M (1998) Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps. Eur J Endocrinol 138:557\u2013561","journal-title":"Eur J Endocrinol"},{"key":"1110_CR19","first-page":"N51","volume":"2","author":"Fuleihan","year":"2002","unstructured":"Fuleihan Gel H (2002) Familial benign hypocalciuric hypercalcemia. J Bone Miner Res 17 Suppl 2: N51\u201356","journal-title":"J Bone Miner Res 17 Suppl"},{"key":"1110_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11864-004-0022-6","volume":"5","author":"Gertner","year":"2004","unstructured":"Gertner ME, Kebebew E (2004) Multiple endocrine neoplasia type 2. Curr Treat Options Oncol 5:315\u2013325","journal-title":"Curr Treat Options Oncol"},{"key":"1110_CR21","doi-asserted-by":"crossref","unstructured":"Gibril F, Schumann M, Pace A, Jensen RT (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83:43\u201383","DOI":"10.1097\/01.md.0000112297.72510.32"},{"key":"1110_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000061050","volume":"28","author":"Gimm","year":"2001","unstructured":"Gimm O (2001) Multiple endocrine neoplasia type 2: clinical aspects. Front Horm Res 28:103\u2013130","journal-title":"Front Horm Res"},{"key":"1110_CR23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1440-1754.2002.00802.x","volume":"38","author":"Hamill","year":"2002","unstructured":"Hamill J, Maoate K, Beasley SW, Corbett R, Evans J (2002) Familial parathyroid carcinoma in a child. J Paediatr Child Health 38:314\u2013317","journal-title":"J Paediatr Child Health"},{"key":"1110_CR24","first-page":"1449","volume":"85","author":"Haven","year":"2000","unstructured":"Haven CJ, Wong FK, van Dam EW et al. (2000) A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 85:1449\u20131454","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1026566418011","volume":"1","author":"Heath","year":"2000","unstructured":"Heath DA (2000) Familial hypocalciuric hypercalcemia. Rev Endocr Metab Disord 1:291\u2013296","journal-title":"Rev Endocr Metab Disord"},{"key":"1110_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1026518502081","volume":"1","author":"Hendy","year":"2000","unstructured":"Hendy GN (2000) Molecular mechanisms of primary hyperparathyroidism. Rev Endocr Metab Disord 1:297\u2013305","journal-title":"Rev Endocr Metab Disord"},{"key":"1110_CR27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/302259","volume":"64","author":"Hobbs","year":"1999","unstructured":"Hobbs MR, Pole AR, Pidwirny GN et al. (1999) Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. Am J Hum Genet 64:518\u2013525","journal-title":"Am J Hum Genet"},{"key":"1110_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K et al. (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657\u2013663","journal-title":"J Med Genet"},{"key":"1110_CR29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jpeds.2004.04.023","volume":"145","author":"Howell","year":"2004","unstructured":"Howell VM, Zori RT, Stalker HJ et al. (2004) A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones. J Pediatr 145:567","journal-title":"J Pediatr"},{"key":"1110_CR30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","volume":"86","author":"Hundahl","year":"1999","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985\u20131995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538\u2013544","journal-title":"Cancer"},{"key":"1110_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jso.20152","volume":"88","author":"Iacobone","year":"2004","unstructured":"Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88:223\u2013228","journal-title":"J Surg Oncol"},{"key":"1110_CR32","first-page":"1006","volume":"108","author":"Jackson","year":"1990","unstructured":"Jackson CE, Norum RA, Boyd SB, Talpos GB, Wilson SD, Taggart RT, Mallette LE (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006\u20131012; discussion 1012\u20131003","journal-title":"Surgery"},{"key":"1110_CR33","first-page":"747","volume":"Endocrinol","author":"Jenkins","year":"1997","unstructured":"Jenkins PJ, Satta MA, Simmgen M et al. (1997) Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin Endocrinol (Oxf) 47:747\u2013751","journal-title":"Clin"},{"key":"1110_CR34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0895-4356(00)00239-0","volume":"53","author":"Jorde","year":"2000","unstructured":"Jorde R, Bonaa KH, Sundsfjord J (2000) Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol 53:1164\u20131169","journal-title":"J Clin Epidemiol"},{"key":"1110_CR35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2169\/internalmedicine.33.123","volume":"33","author":"Kakinuma","year":"1994","unstructured":"Kakinuma A, Morimoto I, Nakano Y et al. (1994) Familial primary hyperparathyroidism complicated with Wilms\u2018 tumor. Intern Med 33:123\u2013126","journal-title":"Intern Med"},{"key":"1110_CR36","first-page":"165","volume":"85","author":"Kassem","year":"2000","unstructured":"Kassem M, Kruse TA, Wong FK, Larsson C, Teh BT (2000) Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab 85:165\u2013167","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1245\/ASO.2005.03.036","volume":"12","author":"Kleinpeter","year":"2005","unstructured":"Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, Perrier ND (2005) Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol 12:260\u2013266","journal-title":"Ann Surg Oncol"},{"key":"1110_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0960-7404(99)00037-7","volume":"8","author":"Koea","year":"1999","unstructured":"Koea JB, Shaw JH (1999) Parathyroid cancer: biology and management. Surg Oncol 8:155\u2013165","journal-title":"Surg Oncol"},{"key":"1110_CR39","first-page":"649","volume":"101","author":"Levin","year":"1987","unstructured":"Levin KE, Galante M, Clark OH (1987) Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery 101:649\u2013660","journal-title":"Surgery"},{"key":"1110_CR40","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1210\/jc.2004-0991","volume":"90","author":"Moon","year":"2005","unstructured":"Moon SD, Park JH, Kim EM et al. (2005) A Novel IVS2\u20131G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 90:878\u2013883","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JBJ, Healey CS et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458\u2013460","journal-title":"Nature"},{"key":"1110_CR42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/BF01665308","volume":"15","author":"Obara","year":"1991","unstructured":"Obara T, Fujimoto Y (1991) Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg 15:738\u2013744","journal-title":"World J Surg"},{"key":"1110_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00509-8","volume":"189","author":"Poisson","year":"2003","unstructured":"Poisson A, Zablewska B, Gaudray P (2003) Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett 189:1-10","journal-title":"Cancer Lett"},{"key":"1110_CR44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0002-9610(81)90382-2","volume":"142","author":"Rosen","year":"1981","unstructured":"Rosen IB, Palmer JA (1981) Fibroosseous tumors of the facial skeleton in association with primary hyperparathyroidism: an endocrine syndrome or coincidence? Am J Surg 142:494\u2013498","journal-title":"Am J Surg"},{"key":"1110_CR45","first-page":"59","volume":"26","author":"Rubello","year":"2001","unstructured":"Rubello D, Casara D, Dwamena BA, Shapiro B (2001) Parathyroid carcinoma. A concise review. Minerva Endocrinol 26:59\u201364","journal-title":"Minerva Endocrinol"},{"key":"1110_CR46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF02067369","volume":"16","author":"Sandelin","year":"1992","unstructured":"Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724\u2013731","journal-title":"World J Surg"},{"key":"1110_CR47","first-page":"487","volume":"83","author":"Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R et al. (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83:487\u2013491","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR48","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722\u20131729","journal-title":"N Engl J Med"},{"key":"1110_CR49","first-page":"2036","volume":"81","author":"Silverberg","year":"1996","unstructured":"Silverberg SJ, Bilezikian JP (1996) Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 81:2036\u20132040","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR50","doi-asserted-by":"crossref","unstructured":"Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN, Marx SJ (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81:1-26","DOI":"10.1097\/00005792-200201000-00001"},{"key":"1110_CR51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"Simonds","year":"2004","unstructured":"Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96\u2013102","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR52","first-page":"362","volume":"75","author":"Streeten","year":"1992","unstructured":"Streeten EA, Weinstein LS, Norton JA et al. (1992) Studies in a kindred with parathyroid carcinoma. J Clin Endocrinol Metab 75:362\u2013366","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR53","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/302097","volume":"63","author":"Teh","year":"1998","unstructured":"Teh BT, Esapa CT, Houlston R et al. (1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. Am J Hum Genet 63:1544\u20131549","journal-title":"Am J Hum Genet"},{"key":"1110_CR54","first-page":"4204","volume":"81","author":"Teh","year":"1996","unstructured":"Teh BT, Farnebo F, Kristoffersson U et al. (1996) Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81:4204\u20134211","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR55","first-page":"2114","volume":"83","author":"Teh","year":"1998","unstructured":"Teh BT, Farnebo F, Twigg S et al. (1998) Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 83:2114\u20132120","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR56","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1136\/jmg.2003.012369","volume":"41","author":"Villablanca","year":"2004","unstructured":"Villablanca A, Calender A, Forsberg L et al. (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41: e32","journal-title":"J Med Genet"},{"key":"1110_CR57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"Warner","year":"2004","unstructured":"Warner J, Epstein M, Sweet A et al. (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41:155\u2013160","journal-title":"J Med Genet"},{"key":"1110_CR58","first-page":"191","volume":"Endocrinol","author":"Wassif","year":"1999","unstructured":"Wassif WS, Farnebo F, Teh BT et al. (1999) Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) 50:191\u2013196","journal-title":"Clin"},{"key":"1110_CR59","first-page":"1485","volume":"77","author":"Wassif","year":"1993","unstructured":"Wassif WS, Moniz CF, Friedman E et al. (1993) Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77:1485\u20131489","journal-title":"J Clin Endocrinol Metab"},{"key":"1110_CR60","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMp038159","volume":"349","author":"Weinstein","year":"2003","unstructured":"Weinstein LS, Simonds WF (2003) HRPT2, a marker of parathyroid cancer. N Engl J Med 349:1691\u20131692","journal-title":"N Engl J Med"},{"key":"1110_CR61","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"Woodard","year":"2005","unstructured":"Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF (2005) Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene 24:1272\u20131276","journal-title":"Oncogene"},{"key":"1110_CR62","doi-asserted-by":"crossref","unstructured":"Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA (1992) Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 71:197\u2013205","DOI":"10.1097\/00005792-199207000-00002"},{"key":"1110_CR63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1507\/endocrj.48.453","volume":"48","author":"Yamashita","year":"2001","unstructured":"Yamashita K, Suzuki S, Yumita W et al. (2001) A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer. Endocr J 48:453\u2013458","journal-title":"Endocr J"},{"key":"1110_CR64","first-page":"67","volume":"Endocrinol","author":"Yoshimoto","year":"1998","unstructured":"Yoshimoto K, Endo H, Tsuyuguchi M et al. (1998) Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features. Clin Endocrinol (Oxf) 48:67\u201372","journal-title":"Clin"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-005-1110-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-005-1110-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-005-1110-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:15:58Z","timestamp":1558566958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-005-1110-2"}},"subtitle":["Indikation zur prophylaktischen Parathyreoidektomie?"],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1007\/s00104-005-1110-2","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}